Update on the Phase 4 ENVISION Confirmatory Study of ADUHELM®

Go back to Update on the Phase 4 ENVISION Confirmatory Study of ADUHELM®
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 250.69 -3.15 (1.24%)
Previous Close $253.84    52 Week High $333.65 
Open $251.68    52 Week Low $223.02 
Day High $252.44    P/E 32.10 
Day Low $246.15    EPS $7.81 
Volume 1,157,339